compound, pharmaceutical composition, use of a compound, method for treating a subject suffering from a pathological condition or disease amenable to phosphodiesterase 4 inhibition and combined product

摘要

COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, METHOD FOR TREATMENT OF A SUBJECT SUFFERING FROM A PATHOLOGICAL CONDITION OR SUSTAINABLE DISEASE DISEASE (Phosphodietherase 4 Inhibition and New Product Referred to 2) therapeutically useful ones, to processes for their preparation and the pharmaceutical composition containing them. Said compounds are potent and selective phosphodiesterase 4 (PDE4) inhibitors and thus are useful in the treatment, prevention and suppression of conditions. diseases, disorders and disorders known to be amenable to PDE4 inhibition, such as asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis or irritable bowel disease.